In-Frame Deletion of Dystrophin Exons 8-50 Results in DMD Phenotype

Area of Science:

• Genetics
• Molecular Biology
• Biotechnology

Background:

• Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene, often deletions leading to reading-frame shifts.
• The reading-frame rule suggests in-frame deletions result in milder Becker muscular dystrophy (BMD).
• Genome editing offers potential for restoring reading frames and producing BMD-like dystrophins in DMD.

Purpose of the Study:

• To investigate the therapeutic potential of deleting exons 8-50 in the DMD gene.
• To evaluate if this specific deletion restores dystrophin function and prevents disease progression.
• To determine if this deletion adheres to the established reading-frame rule.

Main Methods:

• Creation of a novel mouse model (DMDdel8-50) with an in-frame deletion of exons 8-50 in the DMD gene using CRISPR-Cas9.
• Comparison of DMDdel8-50 mice with control mice (C57Bl6/CBA) and previously generated DMDdel8-34 KO mice.
• Assessment of protein expression, localization, histological changes, and physical function in the mouse models.

Main Results:

• The DMDdel8-50 mouse model successfully produced a shortened dystrophin protein.
• This truncated dystrophin was correctly localized on the sarcolemma.
• Despite expression and localization, the shortened protein failed to function like full-length dystrophin and did not prevent disease progression.

Conclusions:

• The deletion of exons 8-50, while in-frame, does not restore dystrophin function in this context.
• This finding suggests that exon 8-50 deletion is an exception to the reading-frame rule.
• Careful in vitro or in vivo study of each genome editing variant is crucial for assessing therapeutic effectiveness.